siRNA treatment decreases triglycerides in clients along with rare condition

.STUDY FEATURE.19 September 2024.

Plozasiran lessened triglyceride degrees through 80% and lowered the risk of pancreatitis in clients along with persistent chylomicronemia, with or even without a genetic medical diagnosis.